Answer
Malignancies, including lymphoma and non-melanoma skin cancer, have been reported with JAK inhibitors. Risk is considered especially carefully in older adults, smokers and people with previous or current cancer.
Sources for this answer
- Jyseleca 100 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
- UK Government